BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• Business

  Claritas Genomics And NextCode Health Partner To Accelerate The Use Of Genome Analysis For Children With Rare Diseases

  December 11, 2014

   · 

  4 min read
• Transcatheter Technologies Expands Platform With Transfemoral System To Complement Its “Truly Repositionable” Trinity Tavi System

  December 11, 2014

   · 

  2 min read
• Biotech Beach

  Woman Care Global To Market The Gynocular™ Portable Colposcope

  December 11, 2014

   · 

  1 min read
• Business

  MACROGEN To Supply “X-Genome” Genome Analysis Service To Institute Of Psychiatry At King’s College London

  December 11, 2014

   · 

  1 min read
• Biotech Beach

  Aethlon Medical Initiates Patient Recruitment For FDAApproved Clinical Study

  December 11, 2014

   · 

  5 min read
• Pharm Country

  Soligenix Receives $617,000 In Non-Dilutive Financing From New Jersey’s Technology Business Tax Certificate Transfer Program

  December 11, 2014

   · 

  4 min read
• Drug Development

  Kamada Ltd. Announces Positive Interim Results From Phase 1/2 Clinical Study Of Its Human Alpha-1 Antitrypsin To Treat Graft-Versus-Host Disease Presented At American Society of Hematology Annual Meeting

  December 11, 2014

   · 

  9 min read
• Lone Star Bio

  Caris Life Sciences Presents Two Studies Demonstrating Utility Of Tumor Profiling: Likelihood Of Response To Immunotherapeutics In HER2-Positive Breast Cancer And The Largest Case Series Comparing Male Breast Cancer To Female Breast Cancer Patients

  December 11, 2014

   · 

  6 min read
• Drug Development

  Otsuka Pharmaceutical Co., Ltd. And H. Lundbeck A/S’s Brexpiprazole Demonstrates Statistically Significant Effects In New Phase 3 Studies In Adult Patients With Schizophrenia Presented At The American College Of Neuropsychopharmacology Annual Meeting

  December 11, 2014

   · 

  8 min read
• Business

  Intersect ENT Announces Changes To Board Of Directors

  December 11, 2014

   · 

  2 min read